The use of eplerenone in therapy-resistant chronic central serous chorioretinopathy

Acta Ophthalmol. 2014 Sep;92(6):e488-90. doi: 10.1111/aos.12392. Epub 2014 Apr 2.

Authors

Myrte B Breukink¹, Anneke I den Hollander, Jan E E Keunen, Camiel J F Boon, Carel B Hoyng

Affiliation

¹ Department of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands.

PMID: 24698599
DOI: 10.1111/aos.12392

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Administration, Oral
Adult
Central Serous Chorioretinopathy / diagnosis
Central Serous Chorioretinopathy / drug therapy*
Central Serous Chorioretinopathy / metabolism
Chronic Disease
Eplerenone
Female
Humans
Male
Middle Aged
Mineralocorticoid Receptor Antagonists / therapeutic use*
Receptors, Mineralocorticoid / metabolism
Spironolactone / analogs & derivatives*
Spironolactone / therapeutic use
Subretinal Fluid
Tomography, Optical Coherence
Treatment Outcome
Visual Acuity / physiology

Substances

Mineralocorticoid Receptor Antagonists
Receptors, Mineralocorticoid
Spironolactone
Eplerenone